Crypto investor Will Harborne has launched LongGame, a $40 million venture capital fund focused on longevity biotechnology. The initiative aims to extend healthy lifespans by three decades through investments in stem cell research, gene editing, and senolytics. The fund plans to integrate decentralized science and tools like DAOs to streamline drug discovery and support global scalability for its portfolio companies. With a team of experts, Harborne hopes to democratize access to life-extending therapies and disrupt global industries, similar to how crypto reshaped traditional finance.
Leave a Reply